Media Summary: Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses why " Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses the key findings of a ... Join The Running Channel Club at to meet like-minded runners, get exclusive content and ...

Time To Clinical Response As A Valuable Metric - Detailed Analysis & Overview

Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses why " Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses the key findings of a ... Join The Running Channel Club at to meet like-minded runners, get exclusive content and ... This session explores the critical methods used to evaluate how effectively neuroblastoma treatments are working. Accurate ... During the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, the Multiple Myeloma Hub spoke to Shaji ... Management expert Peter Drucker said that “what gets measured gets managed.” This is especially true in healthcare, where ...

Your support keeps training free for researchers and health workers everywhere, helping them conduct studies even in Dr. Casey Means discusses the role of continuous glucose monitors in increasing understanding and managing blood glucose ...

Photo Gallery

Time to Clinical Response as a Valuable Metric
LEAP 1 & 2 Post-Hoc Assessment Quantifies Time to Clinical Response
Every Garmin Running Watch Metric Explained
Measuring response to treatment
How do response rates observed in clinical trials translate into real-world outcomes in MM?
Data Matters - II: How to Measure Clinical Outcomes?
Communicating Results to Trial Participants
How to Use & Interpret a Continuous Glucose Monitor (CGM) | Dr. Casey Means & Dr. Andrew Huberman
Sponsored
View Detailed Profile
Time to Clinical Response as a Valuable Metric

Time to Clinical Response as a Valuable Metric

Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses why "

LEAP 1 & 2 Post-Hoc Assessment Quantifies Time to Clinical Response

LEAP 1 & 2 Post-Hoc Assessment Quantifies Time to Clinical Response

Thomas Lodise, PharmD, PhD, professor at Albany College of Pharmacy and Health Sciences, discusses the key findings of a ...

Every Garmin Running Watch Metric Explained

Every Garmin Running Watch Metric Explained

Join The Running Channel Club at https://club.therunningchannel.com/ to meet like-minded runners, get exclusive content and ...

Measuring response to treatment

Measuring response to treatment

This session explores the critical methods used to evaluate how effectively neuroblastoma treatments are working. Accurate ...

How do response rates observed in clinical trials translate into real-world outcomes in MM?

How do response rates observed in clinical trials translate into real-world outcomes in MM?

During the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, the Multiple Myeloma Hub spoke to Shaji ...

Sponsored
Data Matters - II: How to Measure Clinical Outcomes?

Data Matters - II: How to Measure Clinical Outcomes?

Management expert Peter Drucker said that “what gets measured gets managed.” This is especially true in healthcare, where ...

Communicating Results to Trial Participants

Communicating Results to Trial Participants

Your support keeps training free for researchers and health workers everywhere, helping them conduct studies even in

How to Use & Interpret a Continuous Glucose Monitor (CGM) | Dr. Casey Means & Dr. Andrew Huberman

How to Use & Interpret a Continuous Glucose Monitor (CGM) | Dr. Casey Means & Dr. Andrew Huberman

Dr. Casey Means discusses the role of continuous glucose monitors in increasing understanding and managing blood glucose ...